Support legislation allowing Medicare to negotiate prescription drug prices directly.

I’ve supported passing legislation to let Medicare negotiate drug prices directly and led on expanding tele-health access for those on Medicare.

Schatz said he supported legislation for direct Medicare drug-price negotiation.

Candidate Q&A: U.S. Senate — Brian Schatz - Honolulu Civil Beat
primary · interview · model gpt-5.5

CMS states that selected drugs with agreed negotiated prices under the Medicare Drug Price Negotiation Program have maximum fair prices, and that first-cycle prices for 10 Part D drugs go into effect January 1, 2026. The page lists a May 26, 2026 ZIP file of selected drugs and negotiated prices.

Most recent official CMS implementation page located shows Medicare drug-price negotiation operating in 2026, with negotiated maximum fair prices published and first-cycle prices effective in 2026.

delivered unknown

Selected Drugs and Negotiated Prices | CMS
secondary · model gpt-5.5 · confidence 95%

CMS says the Inflation Reduction Act gave Medicare the ability to directly negotiate prices for certain high-expenditure, single-source drugs, and that CMS negotiated prices for 10 Part D drugs that go into effect January 1, 2026.

CMS confirms the statutory authority, completed first negotiation cycle, agreed prices, and 2026 effective date for Medicare-negotiated drug prices.

delivered unknown

Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2026
secondary · model gpt-5.5 · confidence 97%

The Senate roll call for H.R. 5376 shows the question was passage of the bill, the result was bill passed 50-50 with the Vice President voting yea, and Schatz (D-HI) voted Yea.

Schatz voted for the Inflation Reduction Act legislative vehicle that became the Medicare drug negotiation law.

delivered unknown A for effort

U.S. Senate Roll Call Vote 117th Congress, Vote 325
secondary · model gpt-5.5 · confidence 98%

Public Law 117-169 includes Subtitle B, Prescription Drug Pricing Reform, Part 1, Lowering Prices Through Drug Price Negotiation. It establishes a Drug Price Negotiation Program and directs the Secretary to negotiate maximum fair prices for selected drugs, with initial price applicability years beginning in 2026.

The enacted law directly creates Medicare drug price negotiation authority and a negotiation program beginning with 2026 applicability.

delivered unknown

Public Law 117-169, Inflation Reduction Act of 2022
secondary · model gpt-5.5 · confidence 99%

Congress.gov records H.R. 5376 as Public Law 117-169 on August 16, 2022, and the CRS summary says the act requires CMS to negotiate prices of certain prescription drugs under Medicare beginning in 2026.

Congress.gov confirms enactment and summarizes the Medicare drug price negotiation provision.

delivered unknown

H.R.5376 - Inflation Reduction Act of 2022 | Congress.gov
secondary · model gpt-5.5 · confidence 98%

CMS announced that manufacturers of all 15 drugs selected for the third cycle chose to participate, that negotiations occur during 2026, and that negotiated prices will be effective beginning in 2028.

CMS shows the negotiation program has continued beyond the first cycle into 2026 implementation activity, reinforcing that the policy is not abandoned or reversed.

delivered unknown

CMS Announces Manufacturer Participation in Third Cycle of Medicare Drug Price Negotiation
secondary · model gpt-5.5 · confidence 94%